文献速递精神分裂症与精神病性障碍

临床高风险患者的海马病理与精神分裂症发病

Hippocampal Pathology in Clinical High-Risk Patients and the Onset of Schizophrenia.
PubMed 文献 · Biol Psychiatry · 2019-10-03

研究纳入75名符合精神病风险综合征结构化访谈定义的临床高风险(CHR)个体,采用优化磁共振技术测量海马局灶脑血容量、局灶萎缩和谷氨酸浓度,基线成像并随访至2年评估转化。结果发现CHR个体基线谷氨酸/谷氨酰胺升高和局灶脑血容量增高,但仅基线海马局灶萎缩预测转化为综合征性精神病。

要点

  • CHR个体存在海马谷氨酸能异常和局灶脑血容量增高。
  • 仅基线海马局灶萎缩预测转化为综合征性精神病。
  • 海马功能障碍可能是精神分裂症及相关精神病性障碍的早期特征。

核心结论

  • CHR患者存在谷氨酸能异常,但仅那些发展为综合征性精神病的CHR患者表现出海马局灶萎缩。
  • 海马功能障碍是精神分裂症及相关精神病性障碍早期特征的证据增加。

研究设计与样本

  • 研究纳入75名符合精神病风险综合征结构化访谈定义的 attenuated positive symptom psychosis-risk syndrome 的CHR个体。
  • 使用优化磁共振技术测量海马局灶脑血容量、局灶萎缩和谷氨酸浓度,基线成像并随访至2年评估转化为精神病。

主要发现

  • 基线时,与对照组相比,CHR个体有高谷氨酸/谷氨酰胺和功能磁共振成像上 elevated focal cerebral blood volume。
  • 仅基线海马局灶萎缩预测进展为综合征性精神病。

临床怎么用

  • 海马局灶萎缩可作为CHR个体转化为综合征性精神病的预测指标。
  • 谷氨酸能异常和局灶脑血容量增高可用于早期识别CHR个体的海马功能障碍。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We examined neuroimaging-derived hippocampal biomarkers in subjects at clinical high risk (CHR) for psychosis to further characterize the pathophysiology of early psychosis. We hypothesized that glutamate hyperactivity, reflected by increased metabolic activity derived from functional magnetic resonance imaging in the CA1 hippocampal subregion and from proton magnetic resonance spectroscopy-derived hippocampal levels of glutamate/glutamine, represents early hippocampal dysfunction in CHR subjects and is predictive of conversion to syndromal psychosis. METHODS: We enrolled 75 CHR individuals with attenuated positive symptom psychosis-risk syndrome as defined by the Structured Interview for Psychosis-risk Syndromes. We used optimized magnetic resonance imaging techniques to measure 3 validated in vivo pathologies of hippocampal dysfunction-focal cerebral blood volume, focal atrophy, and evidence of elevated glutamate concentrations. All patients were imaged at baseline and were followed for up to 2 years to assess for conversion to psychosis. RESULTS: At baseline, compared with control subjects, CHR individuals had high glutamate/glutamine and elevated focal cerebral blood volume on functional magnetic resonance imaging, but only baseline focal hippocampal atrophy predicted progression to syndromal psychosis. CONCLUSIONS: These findings provide evidence that CHR patients with attenuated psychotic symptoms have glutamatergic abnormalities, although only CHR patients who develop syndromal psychosis exhibit focal hippocampal atrophy. Furthermore, these results support the growing evidence that hippocampal dysfunction is an early feature of schizophrenia and related psychotic disorders.

来源:Biol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Provenzano FA, Guo J, Wall MM, et al. Hippocampal Pathology in Clinical High-Risk Patients and the Onset of Schizophrenia. Biol Psychiatry. 2019. PMID: 31771861. doi:10.1016/j.biopsych.2019.09.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。